https://www.recce.com.au Recce Thu, 09 Oct 2025 23:07:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 https://www.recce.com.au/wp-content/uploads/2023/09/cropped-cropped-favicon-32x32.png https://www.recce.com.au 32 32 https://www.recce.com.au/recce-pharmaceuticals-targets-diabetic-foot-infections-with-first-in-class-synthetic-anti-infective/ https://www.recce.com.au/recce-pharmaceuticals-targets-diabetic-foot-infections-with-first-in-class-synthetic-anti-infective/#respond Thu, 09 Oct 2025 23:07:43 +0000 https://www.recce.com.au/?p=10336 https://www.recce.com.au/recce-pharmaceuticals-targets-diabetic-foot-infections-with-first-in-class-synthetic-anti-infective/feed/ 0 https://www.recce.com.au/recces-recce-327-topical-gel-targets-superbugs-speeds-wound-healing/ https://www.recce.com.au/recces-recce-327-topical-gel-targets-superbugs-speeds-wound-healing/#respond Tue, 19 Aug 2025 05:03:57 +0000 https://www.recce.com.au/?p=10272 https://www.recce.com.au/recces-recce-327-topical-gel-targets-superbugs-speeds-wound-healing/feed/ 0 https://www.recce.com.au/recce-327-topical-gel-shows-strong-preclinical-results/ https://www.recce.com.au/recce-327-topical-gel-shows-strong-preclinical-results/#respond Tue, 19 Aug 2025 05:02:10 +0000 https://www.recce.com.au/?p=10270 https://www.recce.com.au/recce-327-topical-gel-shows-strong-preclinical-results/feed/ 0 https://www.recce.com.au/recce-secures-30m-debt-facility-to-support-phase-iii-trials/ https://www.recce.com.au/recce-secures-30m-debt-facility-to-support-phase-iii-trials/#respond Wed, 18 Jun 2025 02:18:34 +0000 https://www.recce.com.au/?p=10223 https://www.recce.com.au/recce-secures-30m-debt-facility-to-support-phase-iii-trials/feed/ 0 https://www.recce.com.au/break-it-down-recce-partners-with-the-us-army/ https://www.recce.com.au/break-it-down-recce-partners-with-the-us-army/#respond Mon, 28 Apr 2025 03:54:20 +0000 https://www.recce.com.au/?p=10195 https://www.recce.com.au/break-it-down-recce-partners-with-the-us-army/feed/ 0 https://www.recce.com.au/recce-to-expand-phase-ii-trial-for-diabetic-foot-infections/ https://www.recce.com.au/recce-to-expand-phase-ii-trial-for-diabetic-foot-infections/#respond Tue, 22 Apr 2025 23:14:28 +0000 https://www.recce.com.au/?p=10182 https://www.recce.com.au/recce-to-expand-phase-ii-trial-for-diabetic-foot-infections/feed/ 0 https://www.recce.com.au/recce-raising-up-to-15-8m-for-phase-iii-trials/ https://www.recce.com.au/recce-raising-up-to-15-8m-for-phase-iii-trials/#respond Thu, 10 Apr 2025 02:29:04 +0000 https://www.recce.com.au/?p=10178 https://www.recce.com.au/recce-raising-up-to-15-8m-for-phase-iii-trials/feed/ 0 https://www.recce.com.au/biocurious-for-recce-our-near-neighbour-was-the-obvious-place-to-launch-a-diabetes-related-trial/ https://www.recce.com.au/biocurious-for-recce-our-near-neighbour-was-the-obvious-place-to-launch-a-diabetes-related-trial/#respond Thu, 03 Apr 2025 00:59:48 +0000 https://www.recce.com.au/?p=10128 https://www.recce.com.au/biocurious-for-recce-our-near-neighbour-was-the-obvious-place-to-launch-a-diabetes-related-trial/feed/ 0 https://www.recce.com.au/synthetic-gel-shows-utility-across-absssi-company-sees-other-indications/ https://www.recce.com.au/synthetic-gel-shows-utility-across-absssi-company-sees-other-indications/#respond Thu, 06 Mar 2025 22:34:12 +0000 https://www.recce.com.au/?p=10000 https://www.recce.com.au/synthetic-gel-shows-utility-across-absssi-company-sees-other-indications/feed/ 0 https://www.recce.com.au/australian-biotech-points-to-potential-superbug-use-as-gel-treats-skin-infections-in-phase-2-trial/ https://www.recce.com.au/australian-biotech-points-to-potential-superbug-use-as-gel-treats-skin-infections-in-phase-2-trial/#respond Thu, 20 Feb 2025 23:17:17 +0000 https://www.recce.com.au/?p=9908 https://www.recce.com.au/australian-biotech-points-to-potential-superbug-use-as-gel-treats-skin-infections-in-phase-2-trial/feed/ 0